Skip to main content

Pfizer Terminates Phase II Maplirpacept Trial Amid Recruitment Struggles, Keeps Focus on Blood Cancer Pipeline

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 1, 2025 – Pfizer has announced the termination of its Phase II trial evaluating the investigational CD47-targeting fusion protein maplirpacept in diffuse large B-cell lymphoma (DLBCL), citing persistent recruitment difficulties that prevented the study from meeting enrollment targets.

Pharma M&A Reignites in June, Signaling Renewed Momentum Despite Regulatory Headwinds

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 1, 2025 – A late surge of acquisitions in June has reenergized pharmaceutical M&A activity, with six major deals announced that propelled first-half 2025 totals to 32 transactions across the industry. This burst of dealmaking, highlighted by BioNTech’s $1.25 billion acquisition of CureVac and Eli Lilly’s $1.3 billion buyout of Verve Therapeutics, has analysts optimistic that the sector’s cautious stance may finally be easing.

Resilient M&A Amid Regulatory Uncertainty

Ultrarare Disease Treatments Edge Closer with Platform Technologies and Precision Gene Editing

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 1, 2025 – A groundbreaking collaboration that delivered a custom-made CRISPR therapy to a nine-month-old patient with CPS1 deficiency has ignited optimism that ultrarare diseases could soon be addressed on a broader scale, thanks to advances in delivery systems, precision gene editing, and regulatory pathways.

FDA Grants Surge of Regulatory Approvals Across RSV, Cancer, and Hepatitis C Therapeutics in June 2025

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 1, 2025 – A wave of pivotal FDA decisions in June 2025 is reshaping key segments of the pharmaceutical landscape, with new approvals spanning respiratory syncytial virus (RSV) vaccines, advanced cancer treatments, and the first-ever antiviral for acute hepatitis C. These regulatory moves not only expand therapeutic options for patients but also set the stage for intensified competition in critical markets, underscoring strategic opportunities for companies across the biopharmaceutical sector.

spoga+gafa 2025 Underscores Outdoor Living’s Strategic Shift and Previews Ambitious 2026 Vision

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 1, 2025 – spoga+gafa 2025 has firmly established outdoor living as a central pillar of the modern lifestyle economy, setting new benchmarks for the global garden and outdoor sector. Drawing around 26,000 trade visitors from more than 100 countries and over 1,600 exhibitors, the world’s leading trade fair for garden lifestyle & BBQs concluded on a high note, despite ongoing economic uncertainties and geopolitical headwinds. This strong turnout confirms spoga+gafa’s position as the leading platform of the garden industry.

Ricoh Launches Pro C5400 Series to Boost Production Speed and Usability for Print Service Providers

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 1, 2025 – Ricoh has announced the launch of the new Pro™ C5400 series for color production printing, introducing systems that combine increased production speed with enhanced user-friendliness. Designed to meet the diverse needs of commercial print service providers and in-house print centers, the Pro C5400 series builds on the output speed and excellent paper handling of the previous Ricoh Pro™ C5310S/C5300S/Pro C5300SL models, delivering significant improvements in overall performance.

Jakarta Set to Transform Southeast Asia’s Furniture and Hardware Industries with 3-in-1 Mega Exhibition

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – June 27, 2025 – Jakarta will become Southeast Asia’s leading hub for the woodworking, furniture manufacturing, and hardware sectors this September, as three major exhibitions—interzum jakarta, International Hardware Fair Indonesia, and IFMAC & WOODMAC—unite in a groundbreaking 3-in-1 format at JIExpo Kemayoran from September 24–27, 2025.

Koelnmesse Charts Bold Decade-Long Strategy After Record 2024 Performance

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – June 27, 2025 – Koelnmesse has announced a robust new ten-year corporate strategy after closing its centenary year with impressive financial results, signaling confidence in its growth trajectory despite global market challenges. The renowned international trade fair organizer recorded EUR 365.8 million in turnover and EUR 21.3 million in profit for 2024, hosting 76 events worldwide and welcoming over 2.1 million visitors from 197 countries.

Strong Financials and International Expansion Drive Momentum

Innovations in Dental 3D Printing Materials Propel Clinical Excellence and Workflow Integration

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – June 27, 2025 – A new wave of breakthroughs in 3D printing materials for dental applications is redefining the capabilities of digital dentistry, enabling practices to deliver faster, more precise, and highly customized patient care while maintaining clinical safety and efficiency.

Digital Dentures Redefine Prosthetic Dentistry with Streamlined Workflows and Enhanced Patient Outcomes

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – June 27, 2025 – Digital dentures are transforming prosthetic dentistry, delivering a precise, efficient, and patient-friendly alternative to traditional dentures. By leveraging advanced technologies like 3D scanning, CAD/CAM design, and 3D printing, companies like SprintRay are pioneering a workflow that enhances comfort, fit, and aesthetics for patients, while reducing errors and appointment times for dental professionals.

Embracing Cutting-Edge Technology for Superior Results